Chief of the New Mexico Department of Health's (NMDOH) Environmental Health Epidemiology Bureau
Key decision makers in the same organization
Organization Signals
Public Activity & Signals
Board meetings, strategic plans, and buyer signals from Nicholas Wristen’s organization
Sep 28, 2026·BoardMeeting
Board
New Mexico Water Quality Control Commission Special Meeting
The Commission addressed several agenda items, including a joint motion to dismiss in the Ritter Investments LLC case and status updates on compliance matters involving the Otto County Prison Facility and the Mora Mutual Domestic Water Consumers and Mutual Sewage Association. A significant portion of the meeting was dedicated to a public hearing regarding the Triennial Review of surface water standards, specifically focusing on proposed amendments to the New Mexico Administrative Code. The hearing included procedural deliberations regarding the admissibility of rebuttal testimony.
Enterprise
Get verified public-sector contacts at scale
Find verified emails, direct dials, role context, job-change updates, and organization signals across every public-sector account you sell to.
Medical Psilocybin Advisory Board Committee Meeting
The committee focused on establishing evidence-based dosage recommendations for medical psilocybin treatment. Key discussions centered on creating baselines for various disorders, including post-traumatic stress disorder, while emphasizing the importance of clinical judgment in adjusting dosages based on individual patient factors and responses. The committee also discussed the integration of best practices into guidance documents, the ongoing monitoring of research to update protocols, and the balance between providing clear recommendations and maintaining flexibility for practitioners.
Sep 11, 2026·BoardMeeting
Board
Medical Psilocybin Advisory Board Advisory Board Meeting
The Board discussed proposed rules related to the medical psilocybin program, specifically focusing on the patient application and registration process. Key topics included requirements for the patient application, such as the need for photo identification and the confirmation of a qualifying diagnosis. Members raised questions regarding the necessity of the application process, the potential for application rejections, and how the program ensures equitable access for patients, including those from Native American communities. Additionally, the role of facilitators and intermediaries within the program rules was highlighted for further discussion.
Sep 11, 2026·BoardMeeting
Board
Research and Continuous Improvement Committee Committee Meeting
The committee meeting addressed operational logistics and upcoming council scheduling. The primary focus was on establishing protocols for a research and continuous improvement program. Discussions covered quality improvement frameworks, harm reduction strategies, and data reporting systems. Additionally, the committee deliberated on selection principles for psychological screening tools, prioritizing psychometric validity and minimal participant burden while maintaining rigorous clinical standards for medical psilocybin research.
Extracted from official board minutes, strategic plans, and video transcripts.
